AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
Jänne, Pasi A, Yang, James Chih-Hsin, Kim, Dong-Wan, Planchard, David, Ohe, Yuichiro, Ramalingam, Suresh S, Ahn, Myung-Ju, Kim, Sang-We, Su, Wu-Chou, Horn, Leora, Haggstrom, Daniel, Felip, Enriqueta, Kim, Joo-Hang, Frewer, Paul, Cantarini, Mireille, Brown, Kathryn H, Dickinson, Paul A, Ghiorghiu, Serban, Ranson, Malcolm
Published in The New England journal of medicine (30.04.2015)
Published in The New England journal of medicine (30.04.2015)
Get full text
Journal Article
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Herbst, Roy S, Prof, Baas, Paul, Prof, Kim, Dong-Wan, MD, Felip, Enriqueta, MD, Pérez-Gracia, José L, MD, Han, Ji-Youn, Prof, Molina, Julian, MD, Kim, Joo-Hang, Prof, Arvis, Catherine Dubos, MD, Ahn, Myung-Ju, Prof, Majem, Margarita, MD, Fidler, Mary J, MD, de Castro, Gilberto, MD, Garrido, Marcelo, MD, Lubiniecki, Gregory M, MD, Shentu, Yue, PhD, Im, Ellie, MD, Dolled-Filhart, Marisa, PhD, Garon, Edward B, MD
Published in The Lancet (British edition) (09.04.2016)
Published in The Lancet (British edition) (09.04.2016)
Get full text
Journal Article
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Hwang, Sohyun, Kwon, Ah-Young, Jeong, Ju-Yeon, Kim, Sewha, Kang, Haeyoun, Park, Joonsuk, Kim, Joo-Hang, Han, Ok Jin, Lim, Sun Min, An, Hee Jung
Published in Scientific reports (20.01.2020)
Published in Scientific reports (20.01.2020)
Get full text
Journal Article
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
Yang, James Chih-Hsin, Ahn, Myung-Ju, Kim, Dong-Wan, Ramalingam, Suresh S, Sequist, Lecia V, Su, Wu-Chou, Kim, Sang-We, Kim, Joo-Hang, Planchard, David, Felip, Enriqueta, Blackhall, Fiona, Haggstrom, Daniel, Yoh, Kiyotaka, Novello, Silvia, Gold, Kathryn, Hirashima, Tomonori, Lin, Chia-Chi, Mann, Helen, Cantarini, Mireille, Ghiorghiu, Serban, Jänne, Pasi A
Published in Journal of clinical oncology (20.04.2017)
Published in Journal of clinical oncology (20.04.2017)
Get full text
Journal Article
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
Garon, Edward B, Dr, Ciuleanu, Tudor-Eliade, Prof, Arrieta, Oscar, MD, Prabhash, Kumar, Prof, Syrigos, Konstantinos N, Prof, Goksel, Tuncay, Prof, Park, Keunchil, Prof, Gorbunova, Vera, MD, Kowalyszyn, Ruben Dario, MD, Pikiel, Joanna, MD, Czyzewicz, Grzegorz, MD, Orlov, Sergey V, Prof, Lewanski, Conrad R, MD, Thomas, Michael, Prof, Bidoli, Paolo, MD, Dakhil, Shaker, MD, Gans, Steven, MD, Kim, Joo-Hang, Prof, Grigorescu, Alexandru, Prof, Karaseva, Nina, MD, Reck, Martin, MD, Cappuzzo, Federico, MD, Alexandris, Ekaterine, MS, Sashegyi, Andreas, PhD, Yurasov, Sergey, MD, Pérol, Maurice, MD
Published in The Lancet (British edition) (23.08.2014)
Published in The Lancet (British edition) (23.08.2014)
Get full text
Journal Article
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study
Ahn, Myung-Ju, Han, Ji-Youn, Lee, Ki Hyeong, Kim, Sang-We, Kim, Dong-Wan, Lee, Yun-Gyoo, Cho, Eun Kyung, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Jong-Seok, Min, Young Joo, Kim, Jin-Soo, Lee, Sung Sook, Kim, Hye Ryun, Hong, Min Hee, Ahn, Jin Seok, Sun, Jong-Mu, Kim, Heung Tae, Lee, Dae Ho, Kim, Sohee, Cho, Byoung Chul
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
BARLESI, Fabrice, SCHERPEREEL, Arnaud, WONG, Elaine K, PEREZ-MORENO, Pablo, MITCHELL, Lada, GROEN, Harry J. M, RITTMEYER, Achim, PAZZOLA, Antonio, FERRER TUR, Neus, KIM, Joo-Hang, AHN, Myung-Ju, AERTS, Joachim G. J. V, GORBUNOVA, Vera, VIKSTRÖM, Anders
Published in Journal of clinical oncology (20.08.2013)
Published in Journal of clinical oncology (20.08.2013)
Get full text
Journal Article
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
Ciuleanu, Tudor, MD, Brodowicz, Thomas, MD, Zielinski, Christoph, Prof, Kim, Joo Hang, MD, Krzakowski, Maciej, Prof, Laack, Eckart, MD, Wu, Yi-Long, Prof, Bover, Isabel, MD, Begbie, Stephen, MD, Tzekova, Valentina, MD, Cucevic, Branka, MD, Pereira, Jose Rodrigues, MD, Yang, Sung Hyun, MD, Madhavan, Jayaprakash, MD, Sugarman, Katherine P, MD, Peterson, Patrick, PhD, John, William J, MD, Krejcy, Kurt, MD, Belani, Chandra P, Dr
Published in The Lancet (British edition) (24.10.2009)
Published in The Lancet (British edition) (24.10.2009)
Get full text
Journal Article
The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib
Vishwanathan, Karthick, Dickinson, Paul A., So, Karen, Thomas, Karen, Chen, Yuh‐Min, De Castro Carpeño, Javier, Dingemans, Anne‐Marie C., Kim, Hye Ryun, Kim, Joo‐Hang, Krebs, Matthew G., Chih‐Hsin Yang, James, Bui, Khanh, Weilert, Doris, Harvey, R. Donald
Published in British journal of clinical pharmacology (01.06.2018)
Published in British journal of clinical pharmacology (01.06.2018)
Get full text
Journal Article
Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1
Kim, Kyoung-Ju, Moon, Dahye, Kong, So Jung, Lee, Yu Seong, Yoo, Youngeun, Kim, Soyoung, Kim, Chan, Chon, Hong Jae, Kim, Joo-Hang, Choi, Kyung-Ju
Published in Gene therapy (01.04.2021)
Published in Gene therapy (01.04.2021)
Get full text
Journal Article
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer
Cho, Arthur, Hur, Jin, Moon, Yong Wha, Hong, Sae Rom, Suh, Young Joo, Kim, Yun Jung, Im, Dong Jin, Hong, Yoo Jin, Lee, Hye-Jeong, Kim, Young Jin, Shim, Hyo Sup, Lee, Jae Seok, Kim, Joo-Hang, Choi, Byoung Wook
Published in BMC cancer (16.03.2016)
Published in BMC cancer (16.03.2016)
Get full text
Journal Article
The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges
Sang, Yun Beom, Kim, Joo-Hang, Kim, Chang-Gon, Hong, Min Hee, Kim, Hye Ryun, Cho, Byoung Chul, Lim, Sun Min
Published in Frontiers in oncology (03.03.2022)
Published in Frontiers in oncology (03.03.2022)
Get full text
Journal Article
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations
Park, Keunchil, Kim, Jin-Soo, Kim, Joo-Hang, Kim, Young-Chul, Kim, Hoon-Gu, Cho, Eun Kyung, Jin, Jong-Youl, Kim, Miyoung, Märten, Angela, Kang, Jin-Hyoung
Published in BMC cancer (12.07.2021)
Published in BMC cancer (12.07.2021)
Get full text
Journal Article
Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread, Apoptosis Induction, and Efficacy
Kim, Joo-Hang, Lee, Young-Sook, Kim, Hoguen, Huang, Jing-Hua, Yoon, A-Rum, Yun, Chae-Ok
Published in JNCI : Journal of the National Cancer Institute (18.10.2006)
Published in JNCI : Journal of the National Cancer Institute (18.10.2006)
Get full text
Journal Article
Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study
Lee, Jiyun, Ahn, Hee Kyung, Kim, Sang‐We, Han, Ji‐Youn, Lee, Sung Sook, Park, Hyung Soon, Lee, Hyun Woo, Kim, Joo‐Hang, Cho, Eunhan, Huggenberger, Reto, Cho, Byoung Chul
Published in Cancer medicine (Malden, MA) (01.04.2024)
Published in Cancer medicine (Malden, MA) (01.04.2024)
Get full text
Journal Article
A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
Kang, Jin-Hyoung, Lee, Ki-Hyeong, Kim, Dong-Wan, Kim, Sang-We, Kim, Hye Ryun, Kim, Joo-Hang, Choi, Jin-Hyuk, An, Ho Jung, Kim, Jin-Soo, Jang, Joung-Soon, Kim, Bong-Seog, Kim, Heung Tae
Published in British journal of cancer (16.02.2021)
Published in British journal of cancer (16.02.2021)
Get full text
Journal Article
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study
Han, Ji-Youn, Ahn, Myung-Ju, Lee, Ki Hyeong, Lee, Yun-Gyoo, Kim, Dong-Wan, Min, Young Joo, Kim, Sang-We, Cho, Eun Kyung, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Sung Sook, Lee, Na Mi, Jang, Hyun Woo, Han, Heewon, Park, Hyejoo, Lee, Jieon, Cho, Byoung Chul
Published in BMC medicine (08.10.2024)
Published in BMC medicine (08.10.2024)
Get full text
Journal Article
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201
Chul Cho, Byoung, Han, Ji-Youn, Hyeong Lee, Ki, Lee, Yun-Gyoo, Kim, Dong-Wan, Joo Min, Young, Kim, Sang-We, Kyung Cho, Eun, Kim, Joo-Hang, Lee, Gyeong-Won, Sook Lee, Sung, Lee, NaMi, Young Wang, Jang, Park, Hyejoo, Ahn, Myung-Ju
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Get full text
Journal Article
Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations
Lee, Youngjoo, Lee, Geon Kook, Lee, Yeon‐Su, Zhang, Wenji, Hwang, Jung‐Ah, Nam, Byung‐Ho, Kim, Seok Hyun, Kim, Joo‐Hang, Yun, Tak, Han, Ji‐Youn, Kim, Heung Tae, Lee, Jin Soo
Published in Cancer (15.07.2014)
Published in Cancer (15.07.2014)
Get full text
Journal Article